8-K
filed July 19, 2023, 7:59 PM ET
ticker CYCN
CIK 0001755237
other material
confidence high
sentiment positive
materiality 0.15
Cyclerion shareholders approve sale of zagociguat/CY3018 assets and CEO stock issuance
Cyclerion Therapeutics, Inc.
- Shareholders approved Asset Sale Proposal (95% for) to sell zagociguat (CY6463) and CY3018 programs per May 11 APA.
- Shareholders also approved Nasdaq Proposal (96% for) allowing conversion of Series A Preferred held by CEO Peter Hecht into common stock.
- Quorum of ~63% (1,515,929 shares) achieved; adjournment proposal not presented due to sufficient votes.
- Vote results enable closing of asset sale to JW Celtics Investment Corp. and JW Cycle Inc.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Cyclerion Therapeutics, Inc. shareholders approved Approval of issuance of shares of Common Stock upon conversion of Series A Convertible Preferred Stock to comply with Nasdaq Listing Rules (Nasdaq Proposal) at the 2023-07-19 meeting.
- Outcome
- passed
- Meeting
- 2023-07-19
Exact text from the filing
Proposal 2: The Nasdaq Proposal A proposal to approve, for purposes of complying with the Nasdaq Listing Rules, the issuance of shares of Common Stock upon potential conversion of the shares of Cyclerion Preferred Stock issued to Dr. Hecht pursuant to the terms of the Stock Purchase Agreement, to the extent that following such conversion Dr. Hecht would hold 20% or more of the outstanding shares of Common Stock, as further described in the Proxy Statement. The following is a tabulation of the votes with respect to this proposal, which was approved by the Company’s shareholders: For Against Abstentions Broker Non-Votes 1,449,712 65,191 1,026 0
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Cyclerion Therapeutics, Inc. shareholders approved Approval and adoption of the Asset Purchase Agreement and the transactions contemplated thereby (Asset Sale Proposal) at the 2023-07-19 meeting.
- Outcome
- passed
- Meeting
- 2023-07-19
Exact text from the filing
Proposal 1: The Asset Sale Proposal A proposal to approve and adopt the Asset Purchase Agreement and the transactions contemplated thereby, as further described in the Proxy Statement . The following is a tabulation of the votes with respect to this proposal, which was approved by the Company’s shareholders: For Against Abstentions Broker Non-Votes 1,440,138 74,742 1,049 0
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.